MIXED HYPE2025-10-29

Align Technology Inc. Q3-2025

Health Care · Health Care Equipment

Revenue
$996M
YoY Growth
1.8%
EPS
$0.78
Gross Margin
64.2%
Revenue by Segment
Clear Aligner
+2%$806M
Imaging Systems and CAD/CAM Services
-1%$190M

Operator Signal: MIXED

Orthodontic and dental markets remain mixed, especially in North America. International markets (EMEA, APAC, LatAm) are driving volume growth. Restructuring charges of $88M signal serious cost-cutting underway while teens/kids category is a bright spot at 8.3% YoY growth.

Founder Implication

If you're selling into dental or orthodontic practices, expect North American budgets to stay tight. International expansion and pediatric/teen segments are where the growth is — orient your GTM accordingly.

AI Intelligence

HYPE

No specific AI mentions in the earnings press release. ClinCheck Live Plan automates treatment planning but is described as a technology milestone without AI framing.

Mentions: 0

Competitor Intelligence

THREATENED
filed a complaint under Section 337...with the U.S. International Trade Commission against Angelalign Technology

What They Actually Said

I am pleased to report third quarter revenues, Clear Aligner volumes, and non-GAAP operating margins, all above our outlook.

Joe Hogan, President and CEO
growth-signalguidance

While activity in the orthodontic and dental markets remains mixed, especially in North America, the initiatives we're taking to drive consumer demand and patient conversion, including working with our DSO partners, are delivering results.

Joe Hogan, President and CEO
headwindmacro

The year-over-year Clear Aligner volume growth rate improved from Q2 to Q3, for all our top 10 country markets, except for Canada.

Joe Hogan, President and CEO
growth-signal

The breadth and depth of our global business and product portfolio, and consumer preference for the Invisalign brand, are unique advantages that provide balance in a dynamic global market.

Joe Hogan, President and CEO
competition

Forward Guidance

INITIATED
We expect Q4'25 worldwide revenues to be in the range of $1,025M to $1,045M, up sequentially from Q3'25(next quarter)
INITIATED
We expect Q4'25 non-GAAP operating margin to be approximately 26.0%(next quarter)
INITIATED
We expect Q4'25 non-GAAP gross margin to be approximately 71.0%(next quarter)
MAINTAINED
We expect 2025 Clear Aligner volume growth to be mid-single digits and revenue growth to be flat to slightly up from 2024(full year)
MAINTAINED
We expect the 2025 non-GAAP operating margin to be slightly above 22.5%(full year)
MAINTAINED
We expect our investments in capital expenditures for fiscal 2025 to be approximately $100 million(full year)
RAISED
We expect these restructuring actions to improve our GAAP and non-GAAP operating margins by at least 100 basis points year-over-year(full year)

Who Ran This Call

DynamicCEO-Led Call
CEO Share100%
Joe HoganPresident and CEO
CAUTIOUS180 words
Joe Hogan: mixed markets, dynamic global market, delivering results, unique advantages